Llp «abdi Ibrahim Global Pharm» (aigp

Llp «abdi Ibrahim Global Pharm» (aigp) is a pharmaceutical and healthcare company founded in 2012. It specializes in developing over 100 medical treatments for critical health conditions, including diabetes, tuberculosis, HIV, and heart disease. Operating across 6 locations, the company focuses on delivering essential medications to diverse patient populations. Its B2B focus is evident in its operational strategy and market engagement.

With an employee range of 500-1,000 individuals, Llp «abdi Ibrahim Global Pharm» (aigp) maintains a significant operational footprint. The company actively exports its pharmaceutical products to international markets such as Azerbaijan, Uzbekistan, Afghanistan, and Georgia. Furthermore, it collaborates closely with government health programs within Kazakhstan to enhance healthcare access and ensure the availability of affordable medications. Meet Llp «abdi Ibrahim Global Pharm» (aigp)'s team to understand their organizational structure and leadership.

Llp «abdi Ibrahim Global Pharm» (aigp) generated a revenue of $41.7M. Its strategic focus on B2B operations and its presence in both Asian and European markets underscore its commitment to global health initiatives. The company's dedication to addressing serious health conditions positions it as a key player in the pharmaceutical sector, striving to improve patient outcomes through its extensive product portfolio and international reach.